Selenium: uses, evidence, dosing and safety

Selenium is the cleanest example on this site of a nutrient that is genuinely essential and genuinely not worth supplementing.

You need it. Without enough of it, people develop a specific heart disease. And the large trials of giving extra to people who already have enough found no benefit, at a level of certainty nutrition research almost never reaches, alongside two signals of possible harm.

What selenium is

Selenium is an essential trace element, meaning the body cannot make it and needs a small amount from food.

It works almost entirely through a family of proteins that incorporate it. Selenium is predominantly found in the form of selenoproteins, which handle antioxidant defense, thyroid hormone conversion and aspects of immune function.

Dietary intake depends heavily on geology, because plants take selenium from soil and soil content varies enormously between regions. That single fact explains both the deficiency disease below and the difficulty of interpreting studies from different countries.

How selenium works

The selenoproteins are the mechanism. The best known, glutathione peroxidase, is part of the system that limits oxidative damage inside cells. Another group converts thyroid hormone into its active form.

Both jobs are saturable. Once there is enough selenium to build the selenoproteins the body wants, extra selenium has nothing further to do, and the enzymes do not work harder because more raw material arrived.

That is the mechanistic reason the trials below came out the way they did, and it is the general shape of most essential-nutrient stories: a steep benefit from correcting a shortfall, then a flat line.

What the evidence says about selenium and cancer

This is the claim that built the market, and it is the one that has been most thoroughly demolished.

The 2018 Cochrane review is unusually direct. Well-designed and well-conducted RCTs have shown no beneficial effect of selenium supplements in reducing cancer risk (high certainty of evidence).

High certainty of no effect is a rare verdict. Most nutrition questions end in low or very low certainty, which leaves room for hope. This one does not.

Why the idea persisted

Cochrane explains that too. Observational longitudinal studies have shown an inverse association between selenium exposure and risk of some cancer types, but null and direct relations have also been reported, and no systematic pattern suggesting dose-response relations has emerged.

In other words, the observational literature pointed in several directions at once, and the trials that could settle it found nothing. That is the standard arc of a failed nutrition hypothesis.

The harm signals

The review does not stop at no benefit. Some RCTs have raised concerns by reporting a higher incidence of high-grade prostate cancer and type 2 diabetes in participants with selenium supplementation.

Neither is established. Both are reasons not to take a supplement that has already been shown not to help.

What the evidence says about selenium in the SELECT trial

SELECT deserves its own section because it was designed to settle the question and did.

It set out to determine whether selenium, vitamin E, or both could prevent prostate cancer and other diseases with little or no toxicity in relatively healthy men, and randomized 35,533 of them.

The result was flat. Selenium or vitamin E, alone or in combination at the doses and formulations used, did not prevent prostate cancer in this population of relatively healthy men, and there were no significant differences in any other prespecified cancer end points, meaning none large enough to clear the statistical bar.

Longer follow-up made it worse for the other arm. With 54,464 additional person-years of follow-up, the trial reported that dietary supplementation with vitamin E significantly increased the risk of prostate cancer among healthy men.

Selenium itself did not reach that threshold, and the range around its estimate comfortably crossed no-effect. But a trial designed to show prevention that instead documents harm in a neighbouring arm is a strong argument against speculative supplementation generally.

What the evidence says about selenium in critical illness

A separate question, because critically ill patients genuinely do have low selenium levels, and it is the one place a supplement plausibly corrects a deficit.

A Cochrane review examined intravenous selenium in intensive care. The evidence there is weaker and the population is not one anybody self-treats, but it is worth knowing the distinction: giving selenium to a depleted patient in an ICU is a different proposition from a healthy adult taking a capsule.

Myths about selenium, and what the evidence says

“Selenium prevents cancer.” Cochrane, at high certainty: no beneficial effect on cancer risk.

“Brazil nuts are a health food you can eat freely.” They are the richest known source and their content varies wildly with soil. A few nuts a day can push someone toward the toxic range.

“It boosts the immune system.” Correcting a deficiency supports immune function. Adding more on top of sufficiency has not been shown to.

“It fixes thyroid problems.” Selenium is needed to activate thyroid hormone, which is not the same as treating thyroid disease. Anyone with a thyroid condition should be managing it with a doctor.

“More antioxidant is better.” SELECT is the counterexample the whole field should remember: the vitamin E arm of an antioxidant prevention trial ended up with more cancer.

Dosing and forms of selenium

The adult requirement is measured in micrograms, and most diets in developed countries supply it without effort. Brazil nuts, seafood, meat, eggs and cereals are the usual sources.

The window between adequate and excessive is narrower than for most nutrients, which is the practical reason to be careful. Supplements commonly provide amounts at or above a full day’s requirement on top of a diet that already covers it.

Forms include selenomethionine, the organic form used in SELECT, and sodium selenite. There is no good outcome evidence favouring one over another, because there is no good outcome evidence favouring supplementation at all in replete people.

Safety, side effects and who should be careful

Chronic excess causes selenosis: hair loss, brittle or lost nails, a garlic odor on the breath, skin rash, and in severe cases nerve damage. MedlinePlus notes that selenium toxicity is rare in the United States, which reflects a food supply that supplies enough without excess rather than a wide safety margin.

The type 2 diabetes signal from the trials is the one to weigh if you are already at risk, and the high-grade prostate cancer signal if you are a man considering it for prostate health, which is precisely the group most likely to buy it.

Anyone on thyroid medication or being treated for cancer should not add it without telling their clinician.

Who actually runs short of selenium

Deficiency is real and geographically concentrated. Historically, selenium deficiency was associated with a type of cardiomyopathy known as Keshan disease, which was initially documented in China in the 1930s, a disease of the heart muscle in regions with selenium-poor soil.

MedlinePlus records the resolution: Keshan disease caused many childhood deaths in China until the link to selenium was discovered and supplements were given.

That is what correcting a genuine deficiency looks like, and it is the strongest argument for selenium mattering. It is also an argument that has no bearing on someone eating a varied diet in a country with selenium in the soil.

The groups plausibly short today are people with severe gastrointestinal malabsorption, people on long-term intravenous nutrition, and populations in specific low-selenium regions. That is a medical assessment, not a shelf decision.

Interactions

Selenium can interact with thyroid medication, because it participates in thyroid hormone activation.

It may also add to the effect of anticoagulants. And anyone undergoing cancer treatment should raise antioxidant supplements with their oncology team, since the interaction between antioxidants and treatments that work by oxidative damage is an unsettled question.

Bottom line on selenium

If you eat a normal varied diet in a country whose soil contains selenium, you are almost certainly getting enough, and the trials say extra will not help you.

If you are taking it to prevent cancer, that specific claim has been tested at scale and rejected at high certainty, with harm signals attached.

If you are eating a handful of Brazil nuts daily because they are healthy, that is the one realistic route to taking too much.

And if you have a malabsorption condition or are fed intravenously, this is a real clinical question, and the answer belongs to your doctor rather than to a bottle.